Alport syndrome

Search Trials
A Prospective Study of Microalbuminuria in Untreated Boys With Alport Syndrome
Status:
Completed
Last Changed:
Jul 20, 2018
First Changed:
Feb 25, 2008
Disease(s):
Alport Syndrome
Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis
Status:
Not yet recruiting
Last Changed:
Mar 4, 2022
First Changed:
Mar 4, 2022
Disease(s):
Alport Syndrome
Intervention(s):
R3R01
Safety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 Variants
Status:
Not yet recruiting
Last Changed:
Nov 24, 2021
First Changed:
Nov 24, 2021
Disease(s):
Alport Syndrome
Intervention(s):
Ramipril
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Status:
Recruiting
Last Changed:
Mar 7, 2022
First Changed:
Aug 13, 2021
Disease(s):
Focal Segmental Glomerulosclerosis
Intervention(s):
SparsentanSparsentan
Atrasentan in Patients With Proteinuric Glomerular Diseases
Status:
Recruiting
Last Changed:
Mar 16, 2022
First Changed:
Oct 5, 2020
Disease(s):
IgA Nephropathy
Intervention(s):
Atrasentan

Connect. Empower. Inspire.